- Home
- Software Solutions
- Resources
- Corporate
The Study of Avastin® to Reverse AEI in Metastatic Breast Cancer Patients Previously Responsive to Hormonal Therapy
Sponsors:
| Phases:
| |
| Indications | Acronym: | |
| ||
Age Groups:
| Gender: Female | |
Names:
| Enrollment: 30 | |
Additional information about NCT00240071.